This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Université De Rennes, Université Paris-Saclay. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021
Title: Anne Weber Benarous: Innovator in Cholangiocyte Differentiation
Introduction
Anne Weber Benarous is a prominent inventor based in Villejuif, France. She has made significant contributions to the field of medical research, particularly in the differentiation of human cholangiocytes from progenitor cells. Her innovative methods have the potential to impact drug discovery and treatment for cholangiopathies.
Latest Patents
Anne Weber Benarous holds a patent for a method for inducing human cholangiocyte differentiation. This invention relates to a technique for differentiating hepatoblasts into cholangiocytes by culturing them with a specific medium that has interleukin-6 (IL-6) activity. The method can effectively induce cholangiocyte differentiation, which may be beneficial for drug discovery and the development of bioengineered livers. She has 1 patent to her name.
Career Highlights
Throughout her career, Anne Weber Benarous has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paris-Saclay. Her work has been instrumental in advancing the understanding of cholangiocyte biology and its applications in medicine.
Collaborations
Anne has collaborated with notable colleagues, including Anne Dubart Kupperschmitt and Anne Corlu. These partnerships have further enriched her research and contributed to her innovative approaches in the field.
Conclusion
Anne Weber Benarous is a trailblazer in the field of cholangiocyte differentiation, with her patented methods paving the way for advancements in medical research. Her contributions are poised to make a lasting impact on the treatment of cholangiopathies and the development of bioengineered solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile